Read + Share
Lin G, Ge F, Liu Y, Men Y, et al. Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of
Immunotherapy. Int J Cancer 2026 May 20. doi: 10.1002/ijc.70521.
PMID: 42163537
|
 |
|
Lin G, Ge F, Liu Y, Men Y, et al. Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of
Immunotherapy. Int J Cancer 2026 May 20. doi: 10.1002/ijc.70521.
PMID: 42163537
|
|
|
|